IRIS
SCORSETTI, Marta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.318
EU - Europa 2.417
AS - Asia 1.380
AF - Africa 369
SA - Sud America 30
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 17
Totale 16.556
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.231
SG - Singapore 830
FI - Finlandia 635
IE - Irlanda 535
CN - Cina 373
NG - Nigeria 361
DE - Germania 267
FR - Francia 229
IT - Italia 218
NL - Olanda 148
SE - Svezia 140
GB - Regno Unito 106
CA - Canada 81
TR - Turchia 47
IN - India 42
IL - Israele 41
BE - Belgio 31
AU - Australia 22
HK - Hong Kong 20
CZ - Repubblica Ceca 19
RU - Federazione Russa 18
CL - Cile 16
AT - Austria 15
A2 - ???statistics.table.value.countryCode.A2??? 13
BR - Brasile 10
PL - Polonia 10
GR - Grecia 8
NO - Norvegia 8
RO - Romania 8
ES - Italia 7
UA - Ucraina 6
IR - Iran 5
BD - Bangladesh 4
EU - Europa 4
JP - Giappone 4
PA - Panama 4
ID - Indonesia 3
IQ - Iraq 3
NZ - Nuova Zelanda 3
ZA - Sudafrica 3
CO - Colombia 2
DK - Danimarca 2
EG - Egitto 2
HU - Ungheria 2
MX - Messico 2
MY - Malesia 2
PE - Perù 2
SA - Arabia Saudita 2
TW - Taiwan 2
TZ - Tanzania 2
BG - Bulgaria 1
CH - Svizzera 1
KE - Kenya 1
KR - Corea 1
MD - Moldavia 1
PT - Portogallo 1
SI - Slovenia 1
VN - Vietnam 1
Totale 16.556
Salva come PNG Salva come JPEG
Città #
Wilmington 2.602
Chandler 2.172
San Mateo 1.014
Ann Arbor 720
Helsinki 634
Singapore 568
Dublin 532
Leawood 456
Lawrence 438
Princeton 438
Boardman 397
Benin City 361
Shanghai 318
Fairfield 261
Woodbridge 251
New York 228
Paris 226
Ashburn 217
Amsterdam 140
Milan 89
London 80
Seattle 80
Norwalk 71
Toronto 63
San Diego 52
Santa Clara 47
Kocaeli 46
Phoenix 39
Brussels 30
Falkenstein 23
Los Angeles 23
Redwood City 23
Monmouth Junction 19
Des Moines 18
Munich 17
Redmond 17
Pune 16
Brno 14
Vienna 12
Milwaukee 10
Beijing 9
Andover 8
Frankfurt am Main 8
Abbiategrasso 7
Berlin 7
Clearwater 7
Genoa 7
Cambridge 6
Collegeville 6
Hanover 6
Moscow 6
Buffalo 5
Las Vegas 5
São Paulo 5
Cupertino 4
Houston 4
Kemerovo 4
Nuremberg 4
Prague 4
Prineville 4
St Petersburg 4
Tappahannock 4
Taranto 4
Trezzo sull'Adda 4
Antofagasta 3
Apo 3
Athens 3
Central District 3
Chandigarh 3
Durham 3
Eden Prairie 3
Guangzhou 3
Jacksonville 3
Jakarta 3
La Canada Flintridge 3
Lecce 3
New Berlin 3
Ottawa 3
Springfield 3
Tokyo 3
Vaddangi 3
Augusta 2
Bagnara di Romagna 2
Belleville 2
Bogotá 2
Budapest 2
Canberra 2
Charlotte 2
Chennai 2
Council Bluffs 2
Dar es Salaam 2
Falls Church 2
Farmington 2
Hamilton 2
Henderson 2
Jinan 2
Kuala Lumpur 2
Lima 2
Livorno 2
Manchester 2
Totale 12.983
Salva come PNG Salva come JPEG
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 103
11C Choline PET Guided Salvage Radiotherapy with Volumetric Modulation Arc Therapy and Hypofractionation for Recurrent Prostate Cancer after HIFU Failure: Preliminary Results of Tolerability and Acute Toxicity 90
ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CROSS): Single Center Experience 80
Role of Surgical Resection in Patients with Single Large Brain Metastases: Feasibility, Morbidity, and Local Control Evaluation. 77
Survival outcome and prognostic factors after pulmonary metastasectomy in sarcoma patients 73
Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? Analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy 68
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery 68
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases 63
Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation. 62
Adjuvant chemotherapy and hypofractionated VMAT treatment with SIB for early stage breast cancer: A prospective evaluation of acute toxicity and cosmetic results 62
Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients 60
High incidence of hypocalcemia and serum creatinine increase in patients with bone metastases treated with zoledronic acid 59
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 59
Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation 58
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 58
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 58
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis. 57
Applying failure mode effects and criticality analysis in radiotherapy: Lessons learned and perspectives of enhancement 57
Developing an adolescent and young adult (AYA) cancer program in an Italian adult high-volume cancer center. 57
SBRT for unresectable locally advanced pancreatic cancer: clinical outcomes on 100 patients 57
"Reirradiation: hopes and concerns of the radiation oncologist" Reply 56
Can HSRS on tumor bed replace WBRT in resected brain metastases? Results of a phase II study 56
Assessment of prognostic factors in patients with metastatic epidural spinal cord compression (MESCC) from solid tumor after surgery plus radiotherapy: a single institution experience 56
Hypofractionated stereotactic radiation therapy in skull base meningiomas 55
A broad scope knowledge based model for optimization of VMAT in esophageal cancer: validation and assessment of plan quality among different treatment centers. 55
Addition of temozolomide to radiotherapy for treatment of newly diagnosed anaplastic gliomas 55
"Early Clinical Assessment Of Feasibility And Safety In Flattering Filter Free (FFF) Based Stereotactic Body Radiotherapy (SBRT) Treatments" 55
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 55
A Radiomic Approach to Predict Nodal and Distant Relapse in Patients Treated with Stereotactic Body Radiation Therapy for Early Stage NSCLC 55
Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme 55
Adjuvant radiotherapy for malignant pleural mesothelioma: Challenges and pitfalls 54
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach 54
Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. 54
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis. 53
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments. 53
Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top" 53
The use of radiation therapy for oligoprogressive/oligopersistent oncogene driven non small cell lung cancer: state of the art 53
Stereotactic radiotherapy with linear accelerators. Dosage considerations on collimators and photon beam energy 52
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low-Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients. 52
Hypofractionation in current clinical practice: a flash forward to the near future of radiation oncology? 52
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 52
Accuracy evaluation of the optical surface monitoring system on EDGE linear accelerator in a phantom study. 52
Cranio-spinal irradiation with volumetric modulated arc therapy: A multi-institutional treatment experience 52
Organs at risk in lung SBRT 51
Could single-high-dose radiotherapy be considered the new frontier of stereotactic ablative radiation therapy? 51
Adjuvant chemotherapy and hypofractionated VMAT treatment with SIB for early stage breast cancer 51
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent. 51
Plan robustness in field junction region from arcs with different patient orientation in total marrow irradiation with VMAT. 50
Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation 50
Accuracy evaluation of fusion of CT, MR, and SPECT images using commercially available software packages (SRS PLATO and IFS) 50
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 50
A LARGE, MULTICENTER, RETROSPECTIVE STUDY ON EFFICACY AND SAFETY OF STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN OLIGOMETASTATIC OVARIAN CANCER (MITO RT1 STUDY) 50
A Multi-Institutional Analysis on the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Lymph Node Oligometastases in Prostate Cancer Patients 50
Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer 50
Feasibility of stereotactic body radiation therapy with volumetric modulated arc therapy and high intensity photon beams for hepatocellular carcinoma patients. 49
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma 49
Critical Appraisal of the Risk of Secondary Cancer Induction From Breast Radiation Therapy With Volumetric Modulated Arc Therapy Relative to 3D Conformal Therapy. 49
Long-Term Follow-Up of Patients with Metastatic Epidural Spinal Cord Compression from Solid Tumors Submitted for Surgery Followed by Radiation Therapy 49
FIVE FRACTIONS LINAC BASED SBRT FOR LOW - INTERMEDIATE RISK PROSTATE CANCER: PRELIMINARY REPORT OF A PHASE II STUDY WITH FLATTENING FILTER FREE DELIVERY AND SPACE OAR 49
Randomized phase II study of hypofractionated WBI versus APBI using VMAT: early toxicity results 49
HIGH-GRADE GLIOMAS AND IMMUNOTHERAPEUTIC EARLY PHASE CLINICAL TRIALS: A SINGLE-CENTER EXPERIENCE 49
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 49
Long term follow up of Metastatic Epidural Spinal Cord Compression (MESCC) patients from breast cancer treated with surgery followed by radiotherapy. 49
Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series 48
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma 48
Expression of the transcription factor HEY1 in glioblastoma: a preliminary clinical study 48
Adjuvant radiotherapy in endometrial cancer: Volumetric Modulated Intensity Arc Therapy vs 3DRT 48
DCIS treated with breast conservative surgery and radiotherapy: a national multicentre experience 48
Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients 47
A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. 47
Comparison of low dose total marrow/total lymphoid irradiation (TMI/TLI) and TBI in haploidentical transplant platform: a retrospective analysis 47
High-grade gliomas (HGGs) and immunotherapeutic early-phase clinical trials (ieCTs): A single-center experience 47
Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in a observational study 47
Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study. 47
The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancing 47
Results of a feed-back learning process for RapidPlan knowledge based planning 46
Predictive Factors for Response and Survival in a Cohort of Oligometastatic Patients Treated With Stereotactic Body Radiation Therapy 46
Advantages of a system of positioning and localization made of thermo-conformable materials for irradiation of cervicofacial and encephalic lesions treated with stereotactic fractionated radiation 46
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study. 46
A circulating miRNA signature to implement diagnostic imaging analysis in young early-stage breast cancer patients 46
Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience 45
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 45
Critical appraisal of the role of volumetric modulated arc therapy in the radiation therapy management of breast cancer. 45
Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study. 45
The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT) 45
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 45
Dosimetric evaluation of different radiotherapy modalities and calculations for soft tissue sarcoma 45
Linac-based stereotactic body radiation therapy vs moderate hypofractionated radiotherapy in prostate cancer: propensity-score based comparison of outcome and toxicity 45
Applying Lean-Six-Sigma Methodology in radiotherapy: Lessons learned by the breast daily repositioning case. 45
RapidPlan knowledge based planning: iterative learning process and model ability to steer planning strategies 45
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective 45
SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. 45
Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer Report of feasibility and acute toxicity 44
Semiautomatic method to identify the best phase for gated RT in lung region by 4D-PET/CT acquisitions 44
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation 44
RE-IRRADIATION OF LOCALLY RECURRENT PROSTATE CANCER: RESULTS OF EFFICACY AND SAFETY 44
Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy 44
Critical Appraisal of the Treatment Planning Performance of Volumetric Modulated Arc Therapy by Means of a Dual Layer Stacked Multileaf Collimator for Head and Neck, Breast, and Prostate 44
Electrolyte abnormalities and side effects of zoledronate in patients with bone metastases 44
In-vivo dosimetry with Gafchromic films for multi-isocentric VMAT irradiation of total marrow lymph-nodes: a feasibility study. 44
Totale 5.251
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.570
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202056 0 0 0 0 0 0 0 0 0 0 0 56
2020/20214.698 40 51 63 45 17 1.475 604 382 992 521 15 493
2021/20222.197 98 21 31 545 13 10 87 367 195 236 513 81
2022/20236.230 950 184 550 711 552 514 9 520 1.176 533 461 70
2023/20243.204 206 383 736 116 94 318 131 140 134 60 357 529
2024/2025477 107 154 91 67 58 0 0 0 0 0 0 0
Totale 16.862